Scholarly Index
Fu‐Sheng Wang
Chinese PLA General Hospital; 34,737 total citations; 467 total publications; best world rank #60
Chinese PLA General Hospital
34,737Total citations
467Total publications
69H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| COVID-19 Clinical Research Studies | Lifetime | 91 | CN 20 | 99.41 |
| Long-Term Effects of COVID-19 | Lifetime | 116 | CN 5 | 98.70 |
| Hepatitis B Virus Studies | Lifetime | 367 | CN 20 | 98.97 |
| SARS-CoV-2 and COVID-19 Research | Lifetime | 614 | CN 93 | 98.03 |
| Hepatitis C virus research | Lifetime | 994 | CN 40 | 97.60 |
| Immune responses and vaccinations | Lifetime | 961 | CN 42 | 80.07 |
| Hepatitis B Virus Studies | 2021-2025 | 60 | CN 12 | 98.46 |
| COVID-19 Clinical Research Studies | 2021-2025 | 470 | CN 40 | 97.84 |
| Immune Cell Function and Interaction | 2021-2025 | 283 | CN 68 | 96.12 |
| Hepatitis C virus research | 2021-2025 | 148 | CN 13 | 97.31 |
| Liver Disease Diagnosis and Treatment | 2021-2025 | 588 | CN 73 | 97.40 |
| Long-Term Effects of COVID-19 | 2021-2025 | 644 | CN 25 | 94.73 |
| HIV Research and Treatment | 2021-2025 | 241 | CN 26 | 95.00 |
| Mesenchymal stem cell research | 2021-2025 | 506 | CN 162 | 87.43 |
| HIV-related health complications and treatments | 2021-2025 | 497 | CN 18 | 85.01 |
| Immune responses and vaccinations | 2021-2025 | 233 | CN 14 | 80.32 |
| Hepatitis Viruses Studies and Epidemiology | 2021-2025 | 494 | CN 86 | 75.50 |